Norfloxacin—Toxicity for Zebrafish (Danio rerio) Focused on ...
The Effect of Theophylline on Anxiety in Zebrafish (Danio rerio) Megan Conahan* and Dr. Wendy...
1
The Effect of Theophylline on Anxiety in Zebrafish (Danio rerio) Megan Conahan* and Dr. Wendy Boehmler Department of Biological Sciences, York College of Pennsylvania Introduction A 1 and A 2A antagonists have been found to be protective against neurodegenerative diseases. Compounds that have this property are considered neuroprotective. Methylxanthines, such as caffeine and theophylline are nonselective antagonists of the A 1 and A 2A adenosine receptors (Fredholm et al. 1999). Blockade of these receptors has been associated with reduced risk of Alzheimer’s disease and Parkinson’s disease. Both, theophylline and caffeine have been linked to reduced risk of Parkinson’s disease (Xu et al. 2010). Caffeine has also been found to reduce the risk of Alzheimer’s disease (Dall’Igna et al. 2003) Caffeine has been found to cause increased anxiety levels by many different studies (Egan et al. 2009). This is an unwanted side effect, suggesting a potential drawback in using caffeine as a neuroprotective agent. The effect of theophylline on anxiety has been studied very little. It was found in mice that theophylline had a much less potent effect on anxiety (Lopez-Cruz 2014). This suggests that theophylline could be a potential alternative neuroprotective agent. Zebrafish are increasingly being used as a behavioral model organism, specifically in the field of stress and anxiety. They have also been used to study: social behavior, addiction, sleep, learning and memory. Using zebrafish as a model for these behavioral tests has made them a good candidate for accelerated drug discovery. Other advantages of using zebrafish as a model system include, that they are inexpensive and easy to house in large numbers. Hypothesis • We predicted that theophylline would increase anxiety in zebrafish, but, have a weaker effect when compared to caffeine making theophylline an alternative neuroprotective agent to caffeine. Method s Pre-treatment (n=10) 10 minutes 40 zebrafish Pre-treatment of plain tank water (Negative Control) 0.5 mM Caffeine (Positive Control) 0.5 mM Theophylline (Low Dose) 5.0 mM Theophylline (High Dose) Acclimation Time (2 minutes) Behavioral Testing (5 minutes) Results N egative C ontrol P ositive C ontrol Low D ose High D ose 0 2 4 6 N um berofEntries Figure 1.M ean num berofentries into the upperportion ofthe tank by for negative control fish (distilled w ater),positive control fish (0.5 m M caffeine), fish treated w ith a low dose oftheophylline (0.5 m M )and fish treated w ith a high dose oftheophylline (5 m M )Sam ple sizes w ere n=10 foreach treatm entgroup.Errorbars representthe SEM .According to a Kruskal-W allis test,there w as a significantdifference across treatm ent groups.(p= 0.0054).Furtheranalysis by posthoc D unn's m ultiple com parison's testfound the low dose and high dose oftheophylline to be significantly differentcom pared to the positive control.*p< 0.05,**p<0.01 ** * Tim e (% ) N egative C ontrol P ositive C ontrol Low D ose High D ose 0 10 20 30 40 50 Figure 2.M ean percentage oftim e spentin upperportion oftank for negative control fish (distilled w ater),positive control fish (0.5 m M caffeine),fish treated w ith a low dose oftheophylline (0.5 m M )and fish treated w ith a high dose oftheophylline (5 m M )Sam ple sizes w ere n=10 foreach treatm entgroup.Errorbars representSEM .A Kruskal-W allis test indicates thatm eans are significantly different (p=0.0028).Further analysis by posthoc D unn's m ultiple com parisons testfound thatboth the low dose and the high dose oftheophylline w ere significantly different from the positive control.*p< 0.05,**p< 0.01. * ** N egative C ontrol P ositive C ontrol Low D ose High D ose 0 100 200 300 400 Tim e (seconds) Figure 3.M ean am ountoftim e to reach upperportion fornegative control fish (distilled w ater),positive control fish (0.5 m M caffeine),fish treated w ith a low dose oftheophylline (0.5 m M )and fish treated w ith a high dose oftheophylline (5 m M )Sam ple sizes w ere n=10 foreach treatm entgroup. Errorbars representSEM .A Kruskal-W allis testindicated there w as a significantdifference across treatm entgroups (p= 0.0068).According to a posthoc test,the low dose and high dose oftheophylline w ere significantly differentfrom the positive control.*p<0.05,**p<0.01. * * Conclusions • Caffeine significantly increased anxiety levels compared to theophylline • The low dose and high dose of theophylline produced significantly less anxiety than caffeine • This suggests that theophylline would be a good alternative neuroprotective agent when compared to caffeine • Due to the high through put potential of this model system, it will be of great interest to continue to identify and test candidate drugs that can be used as neuroprotective agents. Literature Cited • Dall’Igna, O.P., Porciuncula, L.O., Souza, D.O., Cunha, R.A., Lara, D.R. 2003. Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity. British Journal of Pharmacology. 138: 1207-1209 • Egan, R.J., Bergner, C.L., Hart, P.C., Cachat, J.M., Canavello, P.R., Elegante, M.F., Elkhaya, S.I., Bartels, B.K., Tien, A.K., Tien, D.H, Mohnot, S., Beeson, E., Glasgow, E., Amri, H., Zukowska, Z. Kalueff, A.V. 2009. Understnading behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behavioural Brain Research. 205: 38- 44 • Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E.E. 1999. Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use. Pharmacological Reviews. 51: 83-133 • Lopez-Cruz, L., Pardo, M., Salamone, J.D., Correa, M. 2014. Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: Studies using medium to high doses in animal models. Behavioural Brain Research. 270: 213-222. • Xu, K., Xu,Y.H., Chen, J.F., Schwarzschild, M.A. 2010. Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson Disease. Neuroscience. 167: 475-481. Acknowledgemen ts I would like to thank Dr. Wendy Boehmler and Dr. Bridgette Hagerty for their assistance and advice throughout this project. *This was a blind study http:// en.wikipedia.org (Egan et al. 2009) http://www.dreamstime.com
-
Upload
cecil-booker -
Category
Documents
-
view
215 -
download
2
Transcript of The Effect of Theophylline on Anxiety in Zebrafish (Danio rerio) Megan Conahan* and Dr. Wendy...
The Effect of Theophylline on Anxiety in Zebrafish (Danio rerio)Megan Conahan* and Dr. Wendy Boehmler
Department of Biological Sciences, York College of Pennsylvania
Introduction A1 and A2A antagonists have been found to be protective against neurodegenerative diseases.
Compounds that have this property are considered neuroprotective. Methylxanthines, such as caffeine and theophylline are nonselective antagonists of the A1 and
A2A adenosine receptors (Fredholm et al. 1999). Blockade of these receptors has been associated with reduced risk of Alzheimer’s disease and
Parkinson’s disease. Both, theophylline and caffeine have been linked to reduced risk of Parkinson’s disease (Xu et al.
2010). Caffeine has also been found to reduce the risk of Alzheimer’s disease (Dall’Igna et al. 2003)
Caffeine has been found to cause increased anxiety levels by many different studies (Egan et al. 2009). This is an unwanted side effect, suggesting a potential drawback in using caffeine as a neuroprotective agent.
The effect of theophylline on anxiety has been studied very little. It was found in mice that theophylline had a much less potent effect on anxiety (Lopez-Cruz 2014). This suggests that theophylline could be a potential alternative neuroprotective agent.
Zebrafish are increasingly being used as a behavioral model organism, specifically in the field of stress and anxiety. They have also been used to study: social behavior, addiction, sleep, learning and memory. Using zebrafish as a model for these behavioral tests has made them a good candidate for accelerated drug discovery. Other advantages of using zebrafish as a model system include, that they are inexpensive and easy to house in large numbers.
Hypothesis• We predicted that theophylline would increase anxiety in zebrafish, but, have a weaker
effect when compared to caffeine making theophylline an alternative neuroprotective agent to caffeine.
MethodsPre-treatment (n=10)
10 minutes
40 zebrafish
Pre-treatment of plain tank water
(Negative Control)
0.5 mM Caffeine(Positive Control)
0.5 mM Theophylline(Low Dose)
5.0 mM Theophylline(High Dose)
Acclimation Time(2 minutes)
Behavioral Testing(5 minutes)
Results
Negative Control
Positive Control
Low Dose
High Dose
0
2
4
6
Nu
mb
er o
f E
ntr
ies
Figure 1. Mean number of entries into the upper portion of the tank by fornegative control fish (distilled water), positive control fish (0.5 mM caffeine),fish treated with a low dose of theophylline (0.5 mM) and fish treated with ahigh dose of theophylline (5 mM) Sample sizes were n=10 for eachtreatment group. Error bars represent the SEM. According to aKruskal-Wallis test, there was a significant difference across treatmentgroups. (p= 0.0054). Further analysis by post hoc Dunn's multiplecomparison's test found the low dose and high dose of theophylline to besignificantly different compared to the positive control. *p< 0.05, **p<0.01
** *
Tim
e (
%)
Negative Control
Positive Control
Low Dose
High Dose
0
10
20
30
40
50
Figure 2. Mean percentage of time spent in upper portion of tank fornegative control fish (distilled water), positive control fish (0.5 mMcaffeine), fish treated with a low dose of theophylline (0.5 mM) and fishtreated with a high dose of theophylline (5 mM) Sample sizes were n=10for each treatment group. Error bars represent SEM. A Kruskal-Wallis testindicates that means are significantly different (p=0.0028). Furtheranalysis by posthoc Dunn's multiple comparisons test found that both thelow dose and the high dose of theophylline were significantly differentfrom the positive control. *p< 0.05, **p< 0.01.
*
**
Negative Control
Positive Control
Low Dose
High Dose
0
100
200
300
400
Tim
e (s
eco
nd
s)
Figure 3. Mean amount of time to reach upper portion for negative controlfish (distilled water), positive control fish (0.5 mM caffeine), fish treatedwith a low dose of theophylline (0.5 mM) and fish treated with a high doseof theophylline (5 mM) Sample sizes were n=10 for each treatment group.Error bars represent SEM. A Kruskal-Wallis test indicated there was asignificant difference across treatment groups (p= 0.0068). According toa posthoc test, the low dose and high dose of theophylline weresignificantly different from the positive control. *p<0.05, **p<0.01.
**
Conclusions• Caffeine significantly increased anxiety levels compared to
theophylline • The low dose and high dose of theophylline produced significantly
less anxiety than caffeine• This suggests that theophylline would be a good alternative
neuroprotective agent when compared to caffeine• Due to the high through put potential of this model system, it will be
of great interest to continue to identify and test candidate drugs that can be used as neuroprotective agents.
Literature Cited• Dall’Igna, O.P., Porciuncula, L.O., Souza, D.O., Cunha, R.A., Lara, D.R. 2003. Neuroprotection by caffeine
and adenosine A2A receptor blockade of β-amyloid neurotoxicity. British Journal of Pharmacology. 138: 1207-1209
• Egan, R.J., Bergner, C.L., Hart, P.C., Cachat, J.M., Canavello, P.R., Elegante, M.F., Elkhaya, S.I., Bartels, B.K., Tien, A.K., Tien, D.H, Mohnot, S., Beeson, E., Glasgow, E., Amri, H., Zukowska, Z. Kalueff, A.V. 2009. Understnading behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behavioural Brain Research. 205: 38-44
• Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E.E. 1999. Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use. Pharmacological Reviews. 51: 83-133
• Lopez-Cruz, L., Pardo, M., Salamone, J.D., Correa, M. 2014. Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: Studies using medium to high doses in animal models. Behavioural Brain Research. 270: 213-222.
• Xu, K., Xu,Y.H., Chen, J.F., Schwarzschild, M.A. 2010. Neuroprotection by caffeine: Time course and role of its metabolites in the MPTP model of Parkinson Disease. Neuroscience. 167: 475-481.
AcknowledgementsI would like to thank Dr. Wendy Boehmler and Dr. Bridgette Hagerty for their assistance and advice throughout this project.
*This was a blind study
http://en.wikipedia.org
(Egan et al. 2009)
http://www.dreamstime.com
